Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Abigail Bartosic"'
Autor:
Vinay Shah, Donna Neuberg, Abigail Bartosic, Manila Gaddh, Gemlyn George, Jeffrey I. Zwicker, Siyang Ren, Thomas Bogue, Tzu-Fei Wang, Amer Al Homssi, Gregory C. Connolly, Brian J. Carney, Lisa Baumann Kreuziger
Publikováno v:
Blood Advances
Key Points In patients with cancer with VTE and thrombocytopenia, modified-dose anticoagulation was associated with a lower rate of major hemorrhage.In this cohort, recurrent VTE was not observed after initiation of modified-dose anticoagulation.
Autor:
Bryce A. Kerlin, Ken M. Riedl, Abigail Bartosic, Lai Wei, Ella Lin, Tzu-Fei Wang, Amanda P. Waller
Publikováno v:
Blood Coagulation & Fibrinolysis. 32:16-22
Venous thromboembolism (VTE) is the third most common cardiovascular disease and optimizing treatment is essential. In this single-center pilot study, we sought to investigate the effects of statins in addition to anticoagulation in patients with acu
Autor:
Tzu-Fei Wang, Amanda P. Waller, Ella Lin, Lai Wei, Abigail Bartosic, Ken Riedl, Bryce A. Kerlin
Background: Venous thromboembolism (VTE) is a considerable public health threat. Improving the management of VTE may achieve better long-term outcomes. In this single-center pilot study, we sought to investigate the effects of statins in addition to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5744f1defb8d49dcd5fa70617718f2c
https://doi.org/10.21203/rs.3.rs-32360/v1
https://doi.org/10.21203/rs.3.rs-32360/v1
Autor:
Tzu-Fei Wang, Ying Huang, John C. Byrd, Abigail Bartosic, Gerard Lozanski, Arletta Lozanski, Rui Li, Tamanna Haque, Tzyy-Jye Doong
Publikováno v:
Blood. 138:4297-4297
Background Venous thromboembolism (VTE) is the third most common cardiovascular disease with an incidence over 1% in the elderly. About 50% of VTE is unprovoked, which is associated with higher rates of recurrent VTE and complications such as post-th
Publikováno v:
Blood. 136:36-37
Background: The duration of anticoagulation in patients with catheter-related thrombosis (CRT) has not been studied in a systematic fashion and is not standardized in clinical practice. Consensus guidelines have a weak recommendation for anticoagulat